Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An estimate of the cost of conducting phase II trials in lung cancer.
Evans WK, Dahrouge S, Stapleton J, Quinn C, Pollock D, Waterfield B, Lister D, Hansel F, Smith A. Evans WK, et al. Among authors: quinn c. Lung Cancer. 2000 May;28(2):85-95. doi: 10.1016/s0169-5002(99)00132-4. Lung Cancer. 2000. PMID: 10717326
Impact of randomly assigned "pay-as-you-go" liquefied petroleum gas prices on energy use for cooking: Experimental pilot evidence from rural Rwanda.
Witinok-Huber R, Keller KP, Abimana E, Ahishakiye C, Chang HH, L'Orange C, Manning DT, Mori R, Muhirwa EF, Muhongerwa L, Ntakirutimana T, Puzzolo E, Quinn C, Rosa G, Tanner K, Young BN, Zimmerle D, Kalisa E, Volckens J, Clark ML. Witinok-Huber R, et al. Among authors: quinn c. Energy Sustain Dev. 2024 Jun;80:101455. doi: 10.1016/j.esd.2024.101455. Epub 2024 May 6. Energy Sustain Dev. 2024. PMID: 38799418
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team. Benatar M, et al. Among authors: quinn c. Lancet Neurol. 2024 May 20:S1474-4422(24)00134-0. doi: 10.1016/S1474-4422(24)00134-0. Online ahead of print. Lancet Neurol. 2024. PMID: 38782015
C9orf72 repeat expansions modify risk for secondary motor and cognitive-behavioral symptoms in behavioral-variant frontotemporal degeneration and amyotrophic lateral sclerosis.
Spencer BE, Xie SX, Elman LB, Quinn CC, Amado D, Baer M, Lee EB, Van Deerlin V, Dratch L, Massimo L, Irwin DJ, McMillan CT. Spencer BE, et al. Among authors: quinn cc. medRxiv [Preprint]. 2024 May 1:2024.04.30.24306638. doi: 10.1101/2024.04.30.24306638. medRxiv. 2024. PMID: 38746326 Free PMC article. Preprint.
1,589 results